ArticleEndocrine, metabolic & immune disorders drug targets2026

Fortunellin Elevates the AMPK Pathway to Reduce Lipid Deposition and Immune Disorders in Young Non-Alcoholic Fatty Liver Disease Rats

Nan Ping et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.